Impact Analysis and Related Considerations of Blood Sampling Design on Pharmacokinetic Endpoint Bioequivalence Studies

Wang Yan; Yan Fang; Han Hongcan; Gao Lili; Zhong Lanping; Wei Chunmin; He Ruirui; Li Min

doi:10.16153/j.1002-7777.2026-04-0020

Wang Yan, Yan Fang, Han Hongcan, Gao Lili, Zhong Lanping, Wei Chunmin, He Ruirui, Li Min

Chinese Pharmaceutical Affairs ›› 2026, Vol. 40 ›› Issue (10) : 1284-1290.

PDF(1314 KB)

Chinese Pharmaceutical Affairs ›› 2026, Vol. 40 ›› Issue (10) : 1284-1290. DOI: 10.16153/j.1002-7777.2026-04-0020

Research Progress

Impact Analysis and Related Considerations of Blood Sampling Design on Pharmacokinetic Endpoint Bioequivalence Studies

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 40(10): 1284-1290 https://doi.org/10.16153/j.1002-7777.2026-04-0020

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(1314 KB)

Accesses

Citation

Detail

Sections

Recommended

Please choose a citation manager

Content to export